VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group
- Publication date
- 26 November 2015
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'